We use cookies and tracking technologies to offer you a better browsing experience, analyze site traffic, and improve the website. By clicking “Accept Cookies”, you expressly agree to our use of cookies and tracking technologies in accordance with our Cookie Policy. If you wish to prevent your data from being used by Google Analytics you can opt-out below.
Google Analytics Opt-Out
Contact us
;
  • Patients

    • How We Help
    • Patient Services
    • Patient Stories
    • FAQs
  • Expertise

    • Our Specialties
  • Solutions

    • Providers
    • Manufacturers
    • Payers
  • Who We Are

    • About Us
    • Our History
    • Our Leadership
  • The AmerisourceBergen Network
  • Rx Forms
  • Insights
  • News and Events
  • Careers
Contact Us
  • LinkedIn
  • Twitter
  • Facebook

Patients

  • How We Help
  • Patient Services
  • Patient Stories
  • FAQs

Expertise

  • Our Specialties

Solutions

  • Providers
  • Manufacturers
  • Payers

Who We Are

  • About Us
  • Our History
  • Our Leadership
The AmerisourceBergen Network
Rx Forms
Insights
News and Events
Careers
  • Contact Us
  • LinkedIn
  • Twitter
  • Facebook

October 3, 2018

Joy Gilbert featured in Drug Store News article: "Specialty pharmacies toe the line between access, cost and outcomes"

It seems that not a week goes by without a new specialty drug being launched. In fact, of the 46 novel drugs that the FDA approved in 2017, 18, or nearly 40%, were considered specialty drugs.

Continue reading
Share:

More in the Media

Amish Patel publishes article in Specialty Pharmacy Times: "Hemophilia Advancements and the Evolution of Patient Management"

November 14, 2018

Joy Gilbert featured in Specialty Pharmacy Times video: "How Can Specialty Pharmacies Reduce the Cost of Orphan Drugs?"

August 06, 2018

Kevin James featured in RFID Journal article: "Health-Care, Pharmaceutical Providers Testing RFID to Track Hemophilia Medication"

August 06, 2018

Joy Gilbert featured in Specialty Pharmacy Times video: "How Can Specialty Pharmacies Prepare for New Orphan Drugs?"

July 23, 2018

  • Terms and Conditions
  • Privacy
  • Nondiscrimination Notice
  • Patient Rights
  • Facebook
  • LinkedIn
  • Twitter
Contact Us
Copyright ©2022 AmerisourceBergen Corporation. All Rights Reserved.